Massive Pharma spends billions extra on executives and stockholders than on R&D
Enlarge (credit score: Senate HELP Committee) When massive pharmaceutical corporations are confronted over their exorbitant pricing of prescribed drugs within the US, they typically retreat to 2 well-worn arguments: One, that the excessive drug costs cowl prices of researching and